"What" Series

What are the definitions of Serious risk and Signal of a serious risk?

25 December 2023
2 min read

Serious risk means a risk of a serious adverse drug experience.

Signal of a serious risk means information related to a serious adverse drug experience associated with use of a drug and derived from

(A) a clinical trial;

(B) adverse event reports;

(C) a postapproval study, including a study under section 505(o)(3);

(D) peer-reviewed biomedical literature;

(E) data derived from the postmarket risk identification and analysis system under section 505(k)(4);

(F) other scientific data deemed appropriate by the Secretary.

Deciphering Thrombin Inhibitors and Keeping Up with Their Recent Developments
Deciphering Thrombin Inhibitors and Keeping Up with Their Recent Developments
25 December 2023
Thrombin inhibitors are drugs that specifically target and inhibit thrombin, a key enzyme in blood clotting.
Read →
What is GBS? And what causes GBS?
"What" Series
2 min read
What is GBS? And what causes GBS?
25 December 2023
Guillain-Barré syndrome (GBS) is a rare disorder in which a person’s own immune system damages the nerve cells, causing muscle weakness and sometimes paralysis.
Read →
What are the types of protein amidation modifications and their role in regulation of protein biological activity?
"What" Series
2 min read
What are the types of protein amidation modifications and their role in regulation of protein biological activity?
25 December 2023
Protein amidation is the process through which a carboxyl group is converted into an amide group.
Read →
Agomab Begins Phase I Trial of AGMB-447 in Healthy Subjects and IPF Patients
Latest Hotspot
3 min read
Agomab Begins Phase I Trial of AGMB-447 in Healthy Subjects and IPF Patients
25 December 2023
Agomab Initiates First-Stage Research Trial on AGMB-447 with Healthy Participants and Individuals Diagnosed with Idiopathic Pulmonary Fibrosis.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.